Clinical Trials Directory

Trials / Unknown

UnknownNCT01702116

Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma

Multicenter Randomized Controlled Trial, Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Stony Brook University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a study that compares two types of surgery for rectal cancer. There are two procedures that can be used during this surgery, conventional abdominal resection (APR) and extended (or extralevator) APR. The investigators are doing this research to see whether the extralevator APR increases the likelihood that the edge of the tissue that is removed will be more likely to be free from cancer cells compared with the conventional APR surgery. At this time there is no evidence that one type of procedure is better at this than the other. The objective of this research is to determine whether extralevator APR is more likely to have clean margins (free of cancer) compared to the standard APR surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREextralevator APRExtralevator Abdominoperineal Resection For Rectal Adenocarcinoma. The aim of this modified and more extensive procedure is to remove the levator muscle en bloc with the anal canal and the mesorectum, creating a more "cylindrical" specimen, so that the amount of tissue removed around the tumor will be larger, thereby reducing the probability that the CRM will be positive.
PROCEDUREAPRstandard Abdominoperineal Resection For Rectal Adenocarcinoma

Timeline

Start date
2011-07-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2012-10-05
Last updated
2013-04-25

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01702116. Inclusion in this directory is not an endorsement.